The cancer industry is one of the most lucrative business worldwide. Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. Cancer vaccines can be broadly classified into two segments: prophylactic and therapeutic vaccines. Prophylactic vaccines are used for the prevention of cancer, whereas therapeutic vaccines are used for treatment of cancer. With the rising incidences of cancer and limited treatment options, physicians are being forced to look for precautionary vaccines beyond the conventional treatments. As a result, many companies are now investing in developing prophylactic and therapeutic vaccines to curb this deadly disease.
Browse the complete report @ http://www.orbisresearch.com/reports/index/global-cancer-vaccines-market-and-pipeline-vaccines-analysis-to-2020 .
The prophylactic vaccines currently available in the market include Merck’s Gardasil and GSK’s Cervarix while the only therapeutic vaccine in the market is Dendreon’s Provenge. In the global cancer vaccines market, the prophylactic vaccines segment account for maximum share of the market. However, the market share of prophylactic vaccines is likely to decline continuously during the forecasting period due to the increasing uptake of therapeutic vaccines. The market share of therapeutic cancer vaccines is anticipated to increase during the forecasting period.
In the cancer vaccines market, Merck is the clear leader and is expected to maintain its dominancy over a longer period of time. Dendreon Corporation is the second leading player in Cancer vaccines market accounting for XX% market share in 2014. It is predicted that GSK will account for single digit share of the cancer vaccine market by 2020.
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/175243 .
Global Cancer Vaccines Market – Regional Analysis : The United States is the largest regional market for cancer vaccines. United States accounted for XX% share of the global cancer vaccines market in 2014. The Asian region is the second leading market for cancer vaccines. The European region cancer vaccines market share is anticipated to increase from XX% in 2014 to XX% by the year 2020.
iGATE Research report titled “Global – Cancer Vaccines Market and Pipeline Vaccines Analysis to 2020” is a 213 page report with 26 Figures and 25 Tables. This report analyses the Global Cancer Vaccines Market, Regional Cancer Vaccines Market, Major Deals and Funding in Cancer Vaccines Industry, Cancer Vaccines Pipeline Products Portfolio, Company Wise Cancer Vaccines Pipeline Products and the driving factors and challenges for the Cancer Vaccines Market.
List of Tables:
Table 9-1: NovaRx – Clinical Development Pipeline
Table 10-1: AlphaVax – Clinical Development Pipeline
Table 10-2: Altor BioScience – Clinical Development Pipeline
Table 10-3: Argos Therapeutics – Clinical Development Pipeline
Table 10-4: AVAX Technologies – Clinical Development Pipeline
Table 10-5: Biothera – Clinical Development Pipeline
Table 10-6: Celldex Therapeutics – Clinical Development Pipeline
Table 10-7: CureVac – Clinical Development Pipeline
Table 10-8: Genexine – Clinical Development Pipeline
Table 10-9: GlobeImmune – Clinical Development Pipeline
Table 10-10: Gradalis – Clinical Development Pipeline
Table 10-11: Heat Biologics – Clinical Development Pipeline
Table 10-12: ISA Pharmaceuticals – Clinical Development Pipeline
Table 10-13: ISA101-CervISA – Clinical Study Analysis
Table 10-14: NewLink Genetics – Clinical Development Pipeline
Table 10-15: Northwest Biotherapeutics – Clinical Development Pipeline
Table 10-16: NovaRx – Clinical Development Pipeline
Table 10-17: Sotio – Clinical Development Pipeline
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: email@example.com